Industries · DTC Rx
For brands selling prescription treatments direct to consumers: refill and renewal journeys that help patients stay on therapy, messaging built for medical and legal review, and tracking that keeps health data where it belongs.
Why DTC Rx is different
In most eCommerce, a customer who stops buying is a lost sale. In DTC Rx, a patient who stops refilling may also have stopped a treatment their clinician prescribed. That makes refill timing, renewal prompts and failed-payment recovery more than revenue tactics: done well, they help patients stay on therapy, which is also what makes the business work.
The constraint is that almost every message is regulated content. It has to go through review, it can't over-promise, and it can't leak health information on the way to the inbox.
The specific challenges
Every email, SMS and ad goes through medical, legal and regulatory review. Without a system, the calendar stalls and lifecycle programs never ship.
Benefit claims need balanced risk information, and compounded medications are not FDA-approved, so comparisons to brand-name drugs need careful review.
Patients run out of refills or their prescription expires with no renewal prompt. Revenue and adherence drop together.
Patients paying out of pocket are price-sensitive. Failed cards and surprise price changes end subscriptions quietly.
Product pages, event names and checkout URLs can reveal a condition. Default pixels pass it on to ad platforms.
Prescription drug advertising on Google and Meta is restricted and usually requires certification, typically through LegitScript.
Two kinds of messages
We split the program in two, because the content, the review path and the consent are different.
Working with your reviewers
Every claim, risk statement and disclaimer your reviewers approved, in one place, with where it may be used.
Headers, product blocks, safety copy and footers approved once and assembled into new messages.
Submission and approval dates built into the weekly calendar and monthly roadmap, not added at the end.
What was approved, by whom and when, kept with each live message for audit.
How our services apply
Lifecycle moments
How to take it, what to expect and how to reach the care team, using copy your reviewers approved.
Short service messages that invite questions early, before side effects or doubts turn into a stop.
Timed from days of supply, with one-tap reorder behind a login.
A prompt to book the renewal consult while there's still supply left.
Recovery for failed or expiring cards, before the next shipment is missed.
Metrics that matter
Model retention and its revenue impact with the Retention & Repeat Purchase Rate Calculator.
| Metric | Why it matters |
|---|---|
| On-time refill rate | A practical proxy for adherence and the core of recurring revenue |
| Renewal rate before expiry | Shows whether patients get back to a clinician in time |
| Failed-payment recovery rate | Revenue saved without a new acquisition |
| Review cycle time | Days from draft to approval; the hidden limit on program speed |
| Cohort LTV and CAC payback | Whether acquisition is affordable at real retention |
Tools we work with
FAQ
It depends on your model. Manufacturers and distributors fall under FDA rules for prescription drug promotion, including balanced benefit and risk information. Telehealth and pharmacy models also face FTC, state and ad platform rules, and HIPAA if you're a covered entity. Your regulatory reviewer decides which apply; we build workflows and templates that fit their decisions.
Sometimes, and the line matters. A neutral "your refill is ready" message is usually treated differently from a message promoting a new product, but consent and content rules vary. We keep service and promotional messages in separate flows, with separate consent where needed, and let counsel confirm how each is classified.
By reviewing building blocks instead of every email. An approved claims library, pre-approved modules and review dates built into the calendar mean most new messages are assembled from approved parts. Reviewers see fewer, cleaner submissions, and the program ships on schedule.
Yes, within strict limits. Both platforms restrict prescription drug advertising and usually require certification, typically through LegitScript, and both limit targeting based on health. We plan campaigns around current platform policy and optimize on events that carry no health detail. See also our telehealth and e-pharmacy page.
Start with the Free Profit Audit for a view of your retention, tracking and consent health, or talk it through with a strategist.